Friday, August 4, 2017

FURUKAWA ELECTRIC BEGINS MASS PRODUCING STEALTH DICING TAPE

New Semiconductor Tape Significantly Improves Semiconductor Quality 
 

TOKYO, Aug 3 (Bernama-BUSINESS WIRE) -- Furukawa Electric Co., Ltd. (TOKYO:5801) has begun mass producing expand separation dicing tape, a type of tape for use with semiconductors. Expand separation dicing tape delivers high-grade separation of IC chips from wafers after the stealth dicing process.

Background

Semiconductors have truly become a familiar and necessary part of daily life. Semiconductors will need to offer increased functionality in order to process and utilize the huge amounts of big data that will be generated with the arrival of the age of IoT. These components are expected to continue to grow thinner and denser. Higher grade cutting and separation (dicing) of IC chips from wafers will be required to meet these needs, and a variety of manufacturing methods are already being proposed.

In conventional manufacturing processes, mechanical methods are used to dice wafers into several IC chips. However, in order to obtain chips with better yields and improved quality, methods in which it is made easier for wafers to be broken into chips (such as using a laser to form a modifying layer inside the wafer) and in which wafers are separated and cut by expanding semiconductor tape applied to wafers in a radial direction are gaining recent attention. 

Wednesday, August 2, 2017

RESCALE ANNOUNCES SOUTHEAST ASIA EXPANSION WITH THE APPOINTMENT OF ZAC LEOW AS DIRECTOR, SOUTHEAST ASIA

SINGAPORE, Aug 2 (Bernama-BUSINESS WIRE) -- Rescale, the San Francisco-based global leader for turnkey big compute solutions, is pleased to announce the launch of its Singapore office covering Southeast Asia. The office will be managed by Zac Leow who brings 20 years of regional experience in managing startup company growth related to business applications and hardware infrastructure. He carries a strong track record of bringing new solutions to local markets as well as experience in massively scalable applications, IoT, mobile apps, analytics, security, and cloud-hosted PaaS and SaaS applications. Singapore has fast become a high-tech digital hub for the region, and Leow will be working with local partners to promote Rescale’s leading solutions to end users and IT professionals across multiple industries.
 
“Rescale is at the leading edge of HPC and big compute in the cloud, and has the widest industry software support,” commented Leow. “I am honored to head the Singapore office and to help customers in Southeast Asia accelerate and optimize their engineering and scientific simulations using Rescale’s innovative platform. Rescale has some of the most amazing engineering talents a company can have.”
 
http://mrem.bernama.com/viewsm.php?idm=29723

SUNDANCE ENERGY AUSTRALIA LIMITED ENTERS INTO US$30,000,000 REVENUE ADVANCE FACILITY

DENVER, Aug 1 (Bernama-GLOBE NEWSWIRE) -- Sundance Energy Australia Limited (ASX:SEA) (NASDAQ:SNDE) ("Sundance" or the "Company"), a U.S. onshore oil and gas exploration and production company focused in the Eagle Ford in South Texas, is pleased to announce that it has entered into a $30,000,000 revenue advance facility with Vitol, Inc., part of The Vitol Group which is one of the largest independent energy trading groups in the world.

Oil is priced at market plus or minus any gain or loss on hedging. The revenue advance is repaid through the delivery of oil production at a rate of $20 per gross barrel in Q4 2017 and $25 per gross barrel in Q1 of 2018. The facility may be extended by mutual agreement of the parties.
http://mrem.bernama.com/viewsm.php?idm=29720

INVIVOSCRIBE® RELEASES LEUKOSTRAT® CDX FLT3 MUTATION ASSAY AS CE-MARKED IVD ASSAY KIT

SAN DIEGO, Aug 2 (Bernama-GLOBE NEWSWIRE) -- Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicine®, today announces the release of the CE-marked IVD version of its LeukoStrat® CDx FLT3 Mutation Assay which earlier this year was approved by the FDA1.

The assay identifies both internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, and identifies even large ITD mutations, missed using many current NGS-based assays. The kit includes CE-marked software that interprets data, generates mutant/wildtype signal ratios for ITD and TKD mutations, and predicts response to midostaurin.

http://mrem.bernama.com/viewsm.php?idm=29724